The results showed that high expressions of ISG15, IFI27, OASL, CCL5, ISG20, IFIT3, (Figure 5A) and other 21 ISGs (Supplementary Figure S4) were significantly correlated with improved OS rates in cancer patients receiving ICB therapy. This evidence concerns the gene CCL5 and cancer.